Indeed, it was shown that GSK3β KO mice exhibit improved diastolic and systolic function post-MI, with EF improving already at 4 weeks post-MI, preserved LVEDD being evident after 6 weeks and hemodynamic parameters improving at 8 weeks post-MI [52]. This evidence concerns the gene GSK3B and myocardial infarction.